Paper396780
Activation of the complement system by antibody-antigen complexes: the classical pathway.
Porter RR and 1 other. Adv Protein Chem, 1979. Cited by 183 papers, by iCite.
Cite this record
ConductScience Library. Activation of the complement system by antibody-antigen complexes: the classical pathway. Papers, record 396780. Release papers-2026-11-12-0.1.0, 12 Nov 2026. https://conductscience.org/library/papers/396780
- Sources
- 11 sources
- Release
- papers-2026-11-12-0.1.0
Paper
PubMed's record of the paper, with iCite's citation figures. No abstract is shown.
- Title
- Activation of the complement system by antibody-antigen complexes: the classical pathway.
- PubMed
Topics17
NLM's MeSH indexing of the paper, its major topics first.
| MeSH term | Major |
|---|---|
| Antigen-Antibody Complex | Major topic |
| Complement Activation | Major topic |
| Complement Pathway, Classical | Major topic |
| Complement System Proteins | Major topic |
| Amino Acid Sequence | |
| Animals | |
| Carbohydrates | |
| Complement C1 | |
| Complement C2 | |
| Complement C3 | |
| Complement C4 | |
| Complement C5 | |
| Enzyme Activation | |
| Humans | |
| Macromolecular Substances | |
| Molecular Weight | |
| Protein Binding |
Source PubMed
Cited by67
The papers in our copy of PubMed whose reference list names this one, newest first. iCite, which reads more sources, counts 183 citations.
| PMID | Title | Journal | Year | In Papers | Source |
|---|---|---|---|---|---|
| 42843521 | Monocyte-associated C1q upregulation and complement activation contribute to vascular endothelial and multi-organ injury in severe dengue. | Virol Sin | 2026 | https://conductscience.org/library/papers/42843521 | PubMed |
| 42041579 | Small Subset, Big Impact: Regulatory Function of γδ T Cells in Arteriogenesis. | Cells | 2026 | https://conductscience.org/library/papers/42041579 | PubMed |
| 40622551 | Innate Immune Mechanisms in the Central Nervous System. | Adv Exp Med Biol | 2025 | https://conductscience.org/library/papers/40622551 | PubMed |
| 38339243 | The Role of the Complement in Clear Cell Renal Carcinoma (ccRCC)-What Future Prospects Are There for Its Use in Clinical Practice? | Cancers (Basel) | 2024 | https://conductscience.org/library/papers/38339243 | PubMed |
| 37315680 | A nanobody-based complement inhibitor targeting complement component 2 reduces hemolysis in a complement humanized mouse model of autoimmune hemolytic anemia. | Clin Immunol | 2023 | https://conductscience.org/library/papers/37315680 | PubMed |
| 35563796 | Depletion of γδ T Cells Leads to Reduced Angiogenesis and Increased Infiltration of Inflammatory M1-like Macrophages in Ischemic Muscle Tissue. | Cells | 2022 | https://conductscience.org/library/papers/35563796 | PubMed |
| 32260199 | Kaposi's Sarcoma-Associated Herpesvirus and Host Interaction by the Complement System. | Pathogens | 2020 | https://conductscience.org/library/papers/32260199 | PubMed |
| 31170203 | Different mechanisms of serum complement activation in the plasma of common (Chelydra serpentina) and alligator (Macrochelys temminckii) snapping turtles. | PLoS One | 2019 | https://conductscience.org/library/papers/31170203 | PubMed |
| 30906547 | Anti-Toxoplasma gondii antibodies attach to mouse cancer cell lines but not normal mouse lymphocytes. | Biomed Rep | 2019 | https://conductscience.org/library/papers/30906547 | PubMed |
| 28154610 | The Complement System in Neuropathic and Postoperative Pain. | Open Pain J | 2016 | https://conductscience.org/library/papers/28154610 | PubMed |
| 28067347 | Fc microparticles can modulate the physical extent and magnitude of complement activity. | Biomater Sci | 2017 | https://conductscience.org/library/papers/28067347 | PubMed |
| 24009645 | TUNABLE COMPLEMENT ACTIVATION BY PARTICLES WITH VARIABLE SIZE AND Fc DENSITY. | Nano Life | 2013 | https://conductscience.org/library/papers/24009645 | PubMed |
| 23843682 | Innate immunity and neuroinflammation. | Mediators Inflamm | 2013 | https://conductscience.org/library/papers/23843682 | PubMed |
| 23251215 | Familial atypical hemolytic uremic syndrome: a review of its genetic and clinical aspects. | Clin Dev Immunol | 2012 | https://conductscience.org/library/papers/23251215 | PubMed |
| 18313756 | Highly specific inhibition of C1q globular-head binding to human IgG: a novel approach to control and regulate the classical complement pathway using an engineered single chain antibody variable fragment. | Mol Immunol | 2008 | https://conductscience.org/library/papers/18313756 | PubMed |
| 10854231 | Complement activation promotes muscle inflammation during modified muscle use. | Am J Pathol | 2000 | https://conductscience.org/library/papers/10854231 | PubMed |
| 9893058 | C1 inhibitor removes the entire C1qr2s2 complex from anti-C1Q monoclonal antibodies with low binding affinities. | Immunology | 1998 | https://conductscience.org/library/papers/9893058 | PubMed |
| 9461517 | C1q-mediated chemotaxis by human neutrophils: involvement of gClqR and G-protein signalling mechanisms. | Biochem J | 1998 | https://conductscience.org/library/papers/9461517 | PubMed |
| 7326019 | Binding of fluid-phase complement components C3 and C3b to human lymphocytes. | Biochem J | 1981 | https://conductscience.org/library/papers/7326019 | PubMed |
| 7305948 | Purification and characterization of subcomponent C1q of the first component of mouse complement. | Biochem J | 1981 | https://conductscience.org/library/papers/7305948 | PubMed |
Data dates
The date of each source this release read.
- Trials
- 2026-11-12
- Gene search
- 2026-11-11
- Pipelines
- 2026-09-18
None in this release
- Grants
- Trials
- Comments and corrections
- References
- Genes
- Drugs
- Data
Sources 11
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- HGNCCC0
- iCiteCC BY 4.0
- NCBI GenePublic domain (US government)
- NIH RePORTER's grant and paper linksPublic domain
- Open TargetsCC0 1.0
- PMC's ID filePublic domain (US government)
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- HGNCCC0: https://www.genenames.org/about/license/
- iCiteCC BY 4.0
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH RePORTER's grant and paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PMC's ID fileNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this paper from software.
The record and each of its lists are JSON, twenty rows a page. No key.
GET https://conductscience.org/api/papers/v1/396780
GET https://conductscience.org/api/papers/v1/396780/cited_by?page=2